BioMarin Pharmaceutical Inc.
BMRN
$52.88
$0.300.57%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.22B | 1.56B | 1.48B | 1.43B | 1.27B |
| Total Receivables | 903.91M | 908.21M | 790.27M | 855.86M | 739.18M |
| Inventory | 1.27B | 1.30B | 1.38B | 1.34B | 1.27B |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 205.50M | 185.78M | 204.27M | 177.18M | 181.55M |
| Total Current Assets | 4.61B | 3.95B | 3.85B | 3.81B | 3.47B |
|
|
|||||
| Total Current Assets | 4.61B | 3.95B | 3.85B | 3.81B | 3.47B |
| Net Property, Plant & Equipment | 958.07M | 991.80M | 1.04B | 1.03B | 1.03B |
| Long-term Investments | 196.20M | 196.20M | 196.20M | 196.20M | 196.20M |
| Goodwill | 196.20M | 196.20M | 196.20M | 196.20M | 196.20M |
| Total Other Intangibles | 204.66M | 310.84M | 233.11M | 239.62M | 247.35M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.63B | 1.65B | 1.78B | 1.68B | 1.70B |
| Total Assets | 8.59B | 7.59B | 7.61B | 7.46B | 7.15B |
|
|
|||||
| Total Accounts Payable | 395.47M | 312.77M | 389.67M | 310.80M | 293.75M |
| Total Accrued Expenses | 346.38M | 394.32M | 324.75M | 290.59M | 276.67M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.32M | 8.69M | 7.58M | 7.70M | 6.31M |
| Total Finance Division Other Current Liabilities | 41.98M | 43.26M | 76.44M | 75.16M | 51.48M |
| Total Other Current Liabilities | 41.98M | 43.26M | 76.44M | 75.16M | 51.48M |
| Total Current Liabilities | 793.15M | 759.03M | 798.44M | 684.25M | 628.21M |
|
|
|||||
| Total Current Liabilities | 793.15M | 759.03M | 798.44M | 684.25M | 628.21M |
| Long-Term Debt | 1.43B | 597.18M | 596.66M | 596.16M | 595.65M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 37.01M | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 155.48M | 113.80M | 163.06M | 148.82M | 129.69M |
| Total Liabilities | 2.38B | 1.51B | 1.56B | 1.43B | 1.35B |
|
|
|||||
| Common Stock & APIC | 5.97B | 5.96B | 5.90B | 5.85B | 5.79B |
| Retained Earnings | 259.73M | 154.21M | 200.78M | 231.52M | -9.01M |
| Treasury Stock & Other | -14.69M | -23.98M | -45.23M | -56.24M | 7.97M |
| Total Common Equity | 6.21B | 6.09B | 6.06B | 6.03B | 5.79B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.21B | 6.09B | 6.06B | 6.03B | 5.79B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.21B | 6.09B | 6.06B | 6.03B | 5.79B |
|
|
|||||